Cite
HARVARD Citation
Wei, Y. et al. (2018). Antitumor effects of histone deacetylase inhibitor suberoylanilide hydroxamic acid in epidermal growth factor receptor-mutant non-small-cell lung cancer lines in vitro and in vivo. Anti-cancer drugs. 29 (3), p. . [Online].